We operate or partner to make our medicine available across the globe. To report an adverse event or a product complaint, or to request information about our products, please visit our contact us page. Please note, not all products are available in every country listed on the adverse events page. VASCEPA®/VAZKEPA®▼ (icosapent ethyl) is a prescription-only medicine This means it can only be prescribed by a suitably qualified healthcare professional who can assess its suitability for individual patients. ▼ Vazkepa is subject to additional monitoring in the EU. This will allow quick identification of new safety information. Healthcare professionals and patients are asked to report any suspected adverse reactions.